<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2019-2-17(392)-8-11</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-1274</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Применение комбинации пентоксифиллина и витамина Е в профилактике и лечении радиоиндуцированного фиброза мягких тканей: обзор литературы</article-title><trans-title-group xml:lang="en"><trans-title>Use of a Combination of Pentoxifylline and Vitamin E in Prevention and Treatment of Radioinduced Soft Tissue Fibrosis: a Literature Survey</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткачев</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkachev</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., проф.</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Назаренко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazarenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н.</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тимошкина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Timoshkina</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трофимова</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Trofimova</surname><given-names>O. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., проф.</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глебовская</surname><given-names>В. В. </given-names></name><name name-style="western" xml:lang="en"><surname>Glebovskaya</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н.</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н.</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борисова</surname><given-names>Т.  Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Borisova</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н.</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алиева</surname><given-names>С. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Aliyeva</surname><given-names>S. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н.</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр онкологии имени Н. Н. Блохина» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre of Oncology n. a. N. N. Blokhin</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>27</day><month>11</month><year>2019</year></pub-date><volume>2</volume><issue>17</issue><issue-title>Диагностика и онкотерапия</issue-title><fpage>8</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ткачев С.И., Назаренко А.В., Тимошкина Е.А., Трофимова О.П., Глебовская В.В., Иванов С.М., Борисова Т.Н., Алиева С.Б., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Ткачев С.И., Назаренко А.В., Тимошкина Е.А., Трофимова О.П., Глебовская В.В., Иванов С.М., Борисова Т.Н., Алиева С.Б.</copyright-holder><copyright-holder xml:lang="en">Tkachev S.I., Nazarenko A.V., Timoshkina E.V., Trofimova O.P., Glebovskaya V.V., Ivanov S.M., Borisova T.N., Aliyeva S.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/1274">https://www.med-alphabet.com/jour/article/view/1274</self-uri><abstract><p>Поздние лучевые повреждения, возникающие спустя значительный срок от момента завершения лучевого лечения, могут затрагивать любую анатомическую структуру в пределах облучаемой области и тем самым значительно ухудшать качество жизни онкологических больных. Современные технологии лучевой терапии и научно обоснованные режимы фракционирования дозы лучевого воздействия поспособствовали значительному снижению частоты возникновения поздних лучевых повреждений, однако риск их появления по-прежнему сохраняется. В обзоре представлены данные литературы, посвященные как лечению, так и возможностям медикаментозной профилактики такого позднего лучевого повреждения, как радиоиндуцированный фиброз мягких тканей.</p></abstract><trans-abstract xml:lang="en"><p>Late radiation injuries that occur after a significant period from the moment of completion of the radiation treatment can affect any anatomical structure within the irradiated area and thereby significantly impair the quality of life of cancer patients. Modern technologies of radiation therapy and scientifically based dose fractionation modes of radiation exposure have contributed to a significant reduction in the incidence of late radiation damage, but the risk of their appearance remains. The review presents literature data on both the treatment and the possibilities of drug prevention of late radiation damage, such as radio-induced soft tissue fibrosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>радиоиндуцированный фиброз</kwd><kwd>витамин Е</kwd><kwd>пентоксифиллин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>radio induced fibrosis</kwd><kwd>vitamin E</kwd><kwd>pentoxifylline</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Teresa B Chiao and Audrey J Lee. Role of Pentoxifylline and Vitamin E in Attenuation of Radiation-Induced Fibrosis. Ann Pharmacother 2005;39:516–22.</mixed-citation><mixed-citation xml:lang="en">Teresa B Chiao and Audrey J Lee. Role of Pentoxifylline and Vitamin E in Attenuation of Radiation-Induced Fibrosis. Ann Pharmacother 2005;39:516–22.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Brian O’Sullivan and Wilfred Levin. Late Radiation-Related Fibrosis: Pathogenesis, Manifestations, and Current Management. Seminars in Radiation Oncology, Vol 13, No 3 (July), 2003: pp 274–289.</mixed-citation><mixed-citation xml:lang="en">Brian O’Sullivan and Wilfred Levin. Late Radiation-Related Fibrosis: Pathogenesis, Manifestations, and Current Management. Seminars in Radiation Oncology, Vol 13, No 3 (July), 2003: pp 274–289.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sylvie Delanian, Jean-Louis Lefaix. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiotherapy and Oncology 73 (2004) 119–131.</mixed-citation><mixed-citation xml:lang="en">Sylvie Delanian, Jean-Louis Lefaix. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiotherapy and Oncology 73 (2004) 119–131.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Delanian S, Baillet F, Huart J, Lefaix J-L, Maulard C, Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 1994; 32:12–20.</mixed-citation><mixed-citation xml:lang="en">Delanian S, Baillet F, Huart J, Lefaix J-L, Maulard C, Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 1994; 32:12–20.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Radiol. 1998 Aug;71(848):892–4.</mixed-citation><mixed-citation xml:lang="en">Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Radiol. 1998 Aug;71(848):892–4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mateusz Spałek. Chronic radiation-induced dermatitis: challenges and solutions. Clinical, Cosmetic and Investigational Dermatology 2016:9 473–482</mixed-citation><mixed-citation xml:lang="en">Mateusz Spałek. Chronic radiation-induced dermatitis: challenges and solutions. Clinical, Cosmetic and Investigational Dermatology 2016:9 473–482</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">K. N. Prasad, W. C. Cole, B. Kumar, and K. Che Prasad. Pros and cons of antioxidant use during radiation therapy. Cancer Treatment Reviews 2001; 00: 1–13.</mixed-citation><mixed-citation xml:lang="en">K. N. Prasad, W. C. Cole, B. Kumar, and K. Che Prasad. Pros and cons of antioxidant use during radiation therapy. Cancer Treatment Reviews 2001; 00: 1–13.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sylvie Delanian, Raphael Porcher, Saida Balla-Mekias, and Jean-Louis Lefaix. Randomized, Placebo-Controlled Trial of Combined Pentoxifylline and Tocopherol for Regression of Superficial Radiation-Induced Fibrosis. Journal of Clinical Oncology, Vol 21, No 13 (July 1), 2003: pp 2545–2550</mixed-citation><mixed-citation xml:lang="en">Sylvie Delanian, Raphael Porcher, Saida Balla-Mekias, and Jean-Louis Lefaix. Randomized, Placebo-Controlled Trial of Combined Pentoxifylline and Tocopherol for Regression of Superficial Radiation-Induced Fibrosis. Journal of Clinical Oncology, Vol 21, No 13 (July 1), 2003: pp 2545–2550</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Peiman Haddad, Bita Kalaghchi, Farnaz Amouzegar-Hashemi. Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: A phase II clinical trial. Radiotherapy and Oncology 77 (2005) 324–326</mixed-citation><mixed-citation xml:lang="en">Peiman Haddad, Bita Kalaghchi, Farnaz Amouzegar-Hashemi. Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: A phase II clinical trial. Radiotherapy and Oncology 77 (2005) 324–326</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Marie Magnusson, Peter Ho¨glunda, Karin Johansson, Charlotta Jo¨nsson, Fredrika Killander, Per Malmstro¨m, Anna Weddig, Elisabeth Kjelle´nd. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). European Journal of Cancer 45 (2009) 2488–2495</mixed-citation><mixed-citation xml:lang="en">Marie Magnusson, Peter Ho¨glunda, Karin Johansson, Charlotta Jo¨nsson, Fredrika Killander, Per Malmstro¨m, Anna Weddig, Elisabeth Kjelle´nd. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). European Journal of Cancer 45 (2009) 2488–2495</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobson, G., Bhatia, S., Smith, B. J., Button, A. M., Bodeker, K., Buatti, J.. Randomized Trial of Pentoxifylline and Vitamin E vs Standard Follow-up After Breast Irradiation to Prevent Breast Fibrosis, Evaluated by Tissue Compliance Meter. International Journal of Radiation Oncology*Biology*Physics, 85(3), 2013, 604–608.</mixed-citation><mixed-citation xml:lang="en">Jacobson, G., Bhatia, S., Smith, B. J., Button, A. M., Bodeker, K., Buatti, J.. Randomized Trial of Pentoxifylline and Vitamin E vs Standard Follow-up After Breast Irradiation to Prevent Breast Fibrosis, Evaluated by Tissue Compliance Meter. International Journal of Radiation Oncology*Biology*Physics, 85(3), 2013, 604–608.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Madeline Cook, Nathalie Johnson, Henry Daniel Zegzula, Mark Schray, Margaret Glissmeyer, Leslie Sorenson. Prophylactic use of pentoxifylline (Trental) and vitamin E to prevent capsular contracture after implant reconstruction in patients requiring adjuvant radiation. Am J Surg. 2016 Feb 22</mixed-citation><mixed-citation xml:lang="en">Madeline Cook, Nathalie Johnson, Henry Daniel Zegzula, Mark Schray, Margaret Glissmeyer, Leslie Sorenson. Prophylactic use of pentoxifylline (Trental) and vitamin E to prevent capsular contracture after implant reconstruction in patients requiring adjuvant radiation. Am J Surg. 2016 Feb 22</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kaidar-Person, O., Marks, L. B., &amp; Jones, E. L. (2018). Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer. The Breast Journal. Volume 24, Issue 5, 2018, 709–860</mixed-citation><mixed-citation xml:lang="en">Kaidar-Person, O., Marks, L. B., &amp; Jones, E. L. (2018). Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer. The Breast Journal. Volume 24, Issue 5, 2018, 709–860</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Okunieff, P., Augustine, E., Hicks, J. E., Cornelison, T. L., Altemus, R. M., Naydich, B. G., Gerber, L. H. Pentoxifylline in the Treatment of Radiation-Induced Fibrosis. Journal of Clinical Oncology, 22(11), 2004, 2207–2213.</mixed-citation><mixed-citation xml:lang="en">Okunieff, P., Augustine, E., Hicks, J. E., Cornelison, T. L., Altemus, R. M., Naydich, B. G., Gerber, L. H. Pentoxifylline in the Treatment of Radiation-Induced Fibrosis. Journal of Clinical Oncology, 22(11), 2004, 2207–2213.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Baillet F. Alpha-tocopherol treatment of radiofibrosis post-brachytherapy for breast cancer (abstract 9). Radiother Oncol 1997;97(suppl 43): S 3.</mixed-citation><mixed-citation xml:lang="en">Baillet F. Alpha-tocopherol treatment of radiofibrosis post-brachytherapy for breast cancer (abstract 9). Radiother Oncol 1997;97(suppl 43): S 3.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
